Literature DB >> 27795466

Characteristics of Extended-Spectrum β-Lactamases-Producing Escherichia coli in Fecal Samples of Inpatients of Beijing Tongren Hospital.

Maoye Xu1, Yanyan Fan1, Mei Wang1, Xinxin Lu1.   

Abstract

We aimed to investigate the prevalence of extended-spectrum β-lactamases (ESBL)-producing Escherichia coli in Beijing Tongren hospital and to identify a possible relation between colonization and infection. The clinical data on 650 inpatients between March 2012 and July 2012 were retrospectively reviewed. The prevalence of ESBL-producing E. coli among the inpatients was 25.7% (167/650), with the highest level (50.0%) in the rheumatology ward and the lowest (10.0%) in intensive care units. Hospital stay more than 2 years prior to infection, the use of antibiotics within 3 months of infection, and the use of glucocorticoids or immunosuppressive drugs were found to be significantly associated with carriage of ESBL-producing E. coli (P < 0.05). In total, 76 sequence types (STs) were revealed by multilocus sequence typing. ST38 (n = 12, 7.2%) was the most common ST, followed by ST10 (n = 10, 6.0%) and ST131 and ST167 (n = 9 and 5.4% each). Among the fecal carriers, only one patient had an active infection, which was caused by an ST38 strain. In conclusion, in Beijing Tongren hospital, the prevalence of ESBL-producing E. coli was not high. The risk factors of carriage of ESBL-producing E. coli are hospitalization and use of antibiotics, glucocorticoids, or immunosuppressive drugs. ST38, ST10, ST131, and ST167 are the prominent genotypes, but almost 50.0% of STs were scarcely distributed.

Entities:  

Keywords:  Escherichia coli; antibiotics; extended-spectrum β-lactamases; multilocus sequence typing

Mesh:

Substances:

Year:  2016        PMID: 27795466     DOI: 10.7883/yoken.JJID.2016.023

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  4 in total

1.  Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages.

Authors:  Amee R Manges; Hyun Min Geum; Alice Guo; Thaddeus J Edens; Chad D Fibke; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2019-06-12       Impact factor: 26.132

Review 2.  Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli between healthcare and community settings: a systematic review and meta-analysis.

Authors:  Yihienew M Bezabih; Alemayehu Bezabih; Michel Dion; Eric Batard; Samson Teka; Abiy Obole; Noah Dessalegn; Alelegn Enyew; Anna Roujeinikova; Endalkachew Alamneh; Corinne Mirkazemi; Gregory M Peterson; Woldesellassie M Bezabhe
Journal:  JAC Antimicrob Resist       Date:  2022-06-02

3.  Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in hospital and community settings in Chad.

Authors:  Yann Dumont; Sylvain Godreuil; Oumar Ouchar Mahamat; Abdelsalam Tidjani; Manon Lounnas; Mallorie Hide; Julio Benavides; Calèbe Somasse; Abdoul-Salam Ouedraogo; Soufiane Sanou; Christian Carrière; Anne-Laure Bañuls; Hélène Jean-Pierre
Journal:  Antimicrob Resist Infect Control       Date:  2019-10-31       Impact factor: 4.887

4.  Comparative Genome Analysis of an Extensively Drug-Resistant Isolate of Avian Sequence Type 167 Escherichia coli Strain Sanji with Novel In Silico Serotype O89b:H9.

Authors:  Xiancheng Zeng; Xuelin Chi; Brian T Ho; Damee Moon; Christine Lambert; Richard J Hall; Primo Baybayan; Shihua Wang; Brenda A Wilson; Mengfei Ho
Journal:  mSystems       Date:  2019-02-26       Impact factor: 6.496

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.